Evidence map›Paper›PMID 35939784›Full record

ArticleBlood advances2023

A novel, effective, and efficient strategy for treating sickle cell vaso-occlusive events in the infusion center setting.

Scott A Peslak, Alexis Brimm Akins, Anessa M Foxwell, Marie Iannelli, Carolyn Grande, Delisha Breen, J Eric Russell, Tanya J Uritsky, Farzana A Sayani

Abstract read
In one paragraph

Article in Blood advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Scott A PeslakDivision of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.ORCID 0000-0003-1483-1545
Alexis Brimm AkinsClinical Practices of the University of Pennsylvania, Perelman Center for Advanced Medicine, Philadelphia, PA.
Anessa M FoxwellClinical Practices of the University of Pennsylvania, Perelman Center for Advanced Medicine, Philadelphia, PA.ORCID 0000-0003-4665-0108
Marie IannelliClinical Practices of the University of Pennsylvania, Perelman Center for Advanced Medicine, Philadelphia, PA.
Carolyn GrandeClinical Practices of the University of Pennsylvania, Perelman Center for Advanced Medicine, Philadelphia, PA.
Delisha BreenClinical Practices of the University of Pennsylvania, Perelman Center for Advanced Medicine, Philadelphia, PA.
J Eric RussellDivision of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Tanya J UritskyDepartment of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA.
Farzana A SayaniDivision of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.ORCID 0000-0002-8878-9274

Funding

Individualized Care for At Risk Older AdultsT32NR009356 · NINR · UNIVERSITY OF PENNSYLVANIA · PI Lauren M Massimo, MARY D NAYLOR · 2007 to 2026
$7.8M
Cellular Signaling Pathways in the Regulation of Fetal Hemoglobin for Treatment of Sickle Cell DiseaseK08DK129716 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI PESLAK, SCOTT ALAN · 2021 to 2025
$836k
NIDDK NIH HHS K08 DK129716NINR NIH HHS T32 NR009356
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anemia, Sickle CellPainErythrocytes, AbnormalHumans

Identifiers

PMID35939784
PMCPMC9979427

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.